Chronic relapsing homologous collagen-induced arthritis in DBA/1 mice as a model for testing disease-modifying and remission-inducing therapies

Arthritis and Rheumatism

Volumn 44, Issue 5, 2001, Pages 1215-1224

  Malfait, Anne Marie ^a   Williams, Richard O ^a   Malik, Angela Sara ^a   Maini, Ravinder N ^a   Feldmann, Marc ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; CD3 ANTIGEN; CD4 ANTIGEN; COLLAGEN TYPE 2; CYTOKINE ANTIBODY; FREUND ADJUVANT; INDOMETACIN; INTERLEUKIN 12; OKT 3; OKT 4; SALBUTAMOL; TUMOR NECROSIS FACTOR ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTHROPATHY; ARTICLE; CHRONIC DISEASE; COLLAGEN DISEASE; DRUG MIXTURE; DRUG POTENCY; IMMUNIZATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0035036525     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200105)44:5<1215::aid-anr206>3.0.co;2-%23     Document Type: Article

References (33)

1. Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med 1977;146: 857-68.
2. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature 1980;283:666-8.
3. Stuart JM, Townes AS, Kang AH. Nature and specificity of the immune response to collagen in type II collagen induced arthritis in mice. J Clin Invest 1982;69:673-83.
4. Mauri C, Williams RO, Walmsley M, Feldmann M. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur J Immunol 1996;26:1511-4.
5. Durie FH, Fava RA, Noelle RJ. Collagen-induced arthritis as a model of rheumatoid arthritis. Clin Immunol Immunopathol 1994;73:11-8.
6. Williams RO, Malfait AM, Butler DM, Walmsley MJ, Feldmann M, Maini RN. Combination therapy with DMARDs and biological agents in collagen-induced arthritis. Clin Exp Rheumatol 1999;17: S115-20.
7. Thorbecke GJ, Shah R, Leu CH, Kuruvilla AP, Hardison AM, Palladino MA. Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice. Proc Natl Acad Sci USA 1992;89:7375-9.
8. Williams RO, Feldmann M, Maini RN. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad USA 1992;89:9784-8.
9. Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsikis P, et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α. Arthritis Rheum 1993;36:1681-90.
10. Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α versus placebo in rheumatoid arthritis. Lancet 1994;344:1105-10.
11. Moreland LW, Baumgartner SW, Schift MH, Tindall EA, Weaver AL, Ettlinger RE, et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 1997;337:195-7.
12. Moreland LW, Schiff MH, Baumgartner SW, Tindall EA, Fleischmann RM, Bulpitt KJ, et al. Etanercept therapy in rheumatoid arthritis: a randomized, controlled trial. Ann Intern Med 1999;130: 478-86.
13. Maini RN, Taylor PC. Anti-cytokine therapy for rheumatoid arthritis. Annu Rev Med 2000;51:207-29.
14. Trentham DE. Collagen arthritis as a relevant model for rheumatoid arthritis: evidence pro and con. Arthritis Rheum 1982;25: 911-6.
15. Williams RO. Rodent models of arthritis: relevance for human disease. Clin Exp Immunol 1998;114:330-2.
16. Holmdahl R, Jansson L, Larsson E, Rubin K, Klareskog L. Homologous type II collagen induces chronic and progressive arthritis in mice. Arthritis Rheum 1986;29:106-13.
17. Boissier MC, Feng XZ, Carlioz A, Roudier R, Fournier C. Experimental auto-immune arthritis in mice. I. Homologous type II collagen is responsible for self-perpetuating chronic arthritis. Ann Rheum Dis 1987;46:691-700.
18. Andersson M, Holmdahl R. Analysis of type II collagen-reactive T cells in the mouse. I. Different regulation of autoreactive vs. non-autoreactive anti-type II collagen T-cells in the DBA/1 mouse. Eur J Immunol 1990;20:1061-6.
19. Andersson M, Cremer MA, Terato K, Burkhardt H, Holmdahl R. Analysis of type II collagen reactive T cells in the mouse. II. Different localization of immunodominant T cell epitopes on heterologous and autologous type II collagen. Scand J Immunol 1991;33:505-10.
20. Bayrak S, Holmdahl R, Travers P, Lauster R, Hesse M, Dolling R, et al. T cell response of I-Aq mice to self type II collagen: meshing of the binding motif of the I-Aq molecule with repetitive sequences results in autoreactivity to multiple epitopes. Int Immunol 1997;9:1687-99.
21. Miller ES. Purification of type II collagen by pepsin digestion. Biochemistry 1972;11:4903-9.
22. Nordling C, Karlsson-Parra A, Jansson L, Holmdahl R, Klareskog L. Characterization of a spontaneously occurring arthritis in male DBA/1 mice. Arthritis Rheum 1992;35:717-22.
23. 2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: mechanisms of action. J Immunol 1999;162:6278-83.
24. Butler DM, Malfait AM, Maini RN, Brennan FM, Feldmann M. Anti-IL-12 and anti-TNF antibodies synergistically suppress the progression of murine collagen-induced arthritis. Eur J Immunol 1999;29:2205-12.
25. Malfait AM, Butler DM, Presky DH, Maini RN, Brennan FM, Feldmann M. Blockade of interleukin 12 during the induction of collagen-induced arthritis markedly attenuates the severity of the arthritis. Clin Exp Immunol 1998;111:377-83.
26. Cannon GW, McCall S, Cole BC, Griffiths MM, Radov LA, Ward JR. Effects of indomethacin, cyclosporin, cyclophosphamide, and placebo on collagen-induced arthritis. Agents Actions 1990;29: 315-23.
27. Smith SR, Pennline KJ, Bober LA, Kenworthy-Bott L, Phillips L, Pellerito F, et al. Inhibition of collagen II-induced arthritis in mice - a comparison of the effects of Sch 24937, immunosuppressants and nonsteroidal antiinflammatory drugs on the clinical expression of the disease. Int J Immunopharmacol 1990;12: 165-73.
28. Lipsky PE, van der Heijde DMFM, St. Clair EW, Furst DE, Breedveld FC, Kalden JR, et al. Sustained clinical benefit and prevention of joint damage in rheumatoid arthritis with infliximab and methotrexate. N Engl J Med 2000;343:1594-602.
29. Joosten LA, Lubberts E, Helsen MMA, van den Berg WB. Dual role of IL-12 in early and late stages of murine collagen type II arthritis. J Immunol 1997;159:4094-102.
30. Corthay A, Hansson A-S, Holmdahl R. T lymphocytes are not required for the spontaneous development of entheseal ossification leading to marginal ankylosis in the DBA/1 mouse. Arthritis Rheum 2000;43:844-51.
31. Vingsbo C, Sahlstrand P, Brun JG, Jonsson R, Saxne T, Holmdahl R. Pristane-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes. Am J Pathol 1996;149:1675-83.
32. Vingsbo-Lundberg C, Nordquist N, Olofsson P, Sundvall M, Saxne T, Pettersson U, et al. Genetic control of arthritis onset, severity and chronicity in a model for rheumatoid arthritis in rats. Nat Genet 1998;20:401-4.
33. Malfait AM, Gallily R, Sumariwalla PF, Malik AS, Mechoulam R, Feldmann M. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci U S A 2000;97:9561-6.